These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16931910)

  • 1. Degradation of p63 by Itch.
    Melino G; Knight RA; Cesareni G
    Cell Cycle; 2006 Aug; 5(16):1735-9. PubMed ID: 16931910
    [No Abstract]   [Full Text] [Related]  

  • 2. Itch/AIP4 associates with and promotes p63 protein degradation.
    Rossi M; De Simone M; Pollice A; Santoro R; La Mantia G; Guerrini L; Calabrò V
    Cell Cycle; 2006 Aug; 5(16):1816-22. PubMed ID: 16861923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73.
    Levy D; Adamovich Y; Reuven N; Shaul Y
    Cell Death Differ; 2007 Apr; 14(4):743-51. PubMed ID: 17110958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [TUMOR SUPPRESSOR p63 REGULATES EXPRESSION OF UBIQUITIN LIGASE Pirh2].
    Daks AA; Petukhov AV; Shuvalov OY; Vasilieva EA; Melino G; Barlev NA; Fedorova OA
    Tsitologiia; 2015; 57(12):876-9. PubMed ID: 26995965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin-protein ligase Itch regulates p73 stability.
    Rossi M; De Laurenzi V; Munarriz E; Green DR; Liu YC; Vousden KH; Cesareni G; Melino G
    EMBO J; 2005 Feb; 24(4):836-48. PubMed ID: 15678106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2 promotes the proteasomal degradation of p73 through the interaction with Itch in HeLa cells.
    Kubo N; Okoshi R; Nakashima K; Shimozato O; Nakagawara A; Ozaki T
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):405-11. PubMed ID: 21093410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.
    Li Y; Zhou Z; Chen C
    Cell Death Differ; 2008 Dec; 15(12):1941-51. PubMed ID: 18806757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation.
    Jung YS; Qian Y; Chen X
    J Biol Chem; 2011 Oct; 286(41):35388-35395. PubMed ID: 21852228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A regulatory circuit controlling Itch-mediated p73 degradation by Runx.
    Levy D; Reuven N; Shaul Y
    J Biol Chem; 2008 Oct; 283(41):27462-27468. PubMed ID: 18701449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation.
    Sampath D; Calin GA; Puduvalli VK; Gopisetty G; Taccioli C; Liu CG; Ewald B; Liu C; Keating MJ; Plunkett W
    Blood; 2009 Apr; 113(16):3744-53. PubMed ID: 19096009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of p53 protein family in gastrointestinal malignancies.
    Zaika AI; El-Rifai W
    Cell Death Differ; 2006 Jun; 13(6):935-40. PubMed ID: 16557273
    [No Abstract]   [Full Text] [Related]  

  • 12. Deregulated expression of E2F1 promotes proteolytic degradation of tumor suppressor p73 and inhibits its transcriptional activity.
    Ozaki T; Okoshi R; Ono S; Kubo N; Nakagawara A
    Biochem Biophys Res Commun; 2009 Sep; 387(1):143-8. PubMed ID: 19576172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P63 mutations are not a major cause of non-syndromic split hand/foot malformation.
    de Mollerat XJ; Everman DB; Morgan CT; Clarkson KB; Rogers RC; Colby RS; Aylsworth AS; Graham JM; Stevenson RE; Schwartz CE
    J Med Genet; 2003 Jan; 40(1):55-61. PubMed ID: 12525544
    [No Abstract]   [Full Text] [Related]  

  • 14. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
    Boominathan L
    Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UFD2a mediates the proteasomal turnover of p73 without promoting p73 ubiquitination.
    Hosoda M; Ozaki T; Miyazaki K; Hayashi S; Furuya K; Watanabe K; Nakagawa T; Hanamoto T; Todo S; Nakagawara A
    Oncogene; 2005 Nov; 24(48):7156-69. PubMed ID: 16170377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5th International p63/p73 Workshop: much more than just tumour suppression.
    Kadakia MP; Caron de Fromentel C; Sabapathy K
    Cell Death Differ; 2012 Mar; 19(3):549-50. PubMed ID: 22240899
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic prospects for p73 and p63: rising from the shadow of p53.
    Vilgelm A; El-Rifai W; Zaika A
    Drug Resist Updat; 2008; 11(4-5):152-63. PubMed ID: 18801697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Netrin-1 induces apoptosis in human cervical tumor cells via the TAp73alpha tumor suppressor.
    Roperch JP; El Ouadrani K; Hendrix A; Emami S; De Wever O; Melino G; Gespach C
    Cancer Res; 2008 Oct; 68(20):8231-9. PubMed ID: 18922894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p73 and p63: why do we still need them?
    Blandino G; Dobbelstein M
    Cell Cycle; 2004 Jul; 3(7):886-94. PubMed ID: 15254416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.